Janney Montgomery Scott
IHE icon

Janney Montgomery Scott’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Janney Montgomery Scott’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$595K Sell
6,865
-3,536
-34% -$310K ﹤0.01% 1937
2025
Q4 		$882K Buy
10,401
+3,656
+54% +$292K ﹤0.01% 1812
2025
Q3 		$489K Sell
6,745
-84
-1% -$5.8K ﹤0.01% 2157
2025
Q2 		$448K Sell
6,829
-422
-6% -$27.5K ﹤0.01% 2081
2025
Q1 		$512K Buy
7,251
+552
+8% +$38.4K ﹤0.01% 1968
2024
Q4 		$440K Buy
6,699
+261
+4% +$18K ﹤0.01% 2076
2024
Q3 		$455K Sell
6,438
-3,629
-36% -$253K ﹤0.01% 2036
2024
Q2 		$668K Sell
10,067
-2,422
-19% -$159K ﹤0.01% 1684
2024
Q1 		$848K Sell
12,489
-23,904
-66% -$1.58M ﹤0.01% 1616
2023
Q4 		$2.25M Buy
36,393
+342
+0.9% +$20.1K 0.01% 1053
2023
Q3 		$2.13M Sell
36,051
-7,395
-17% -$454K 0.01% 995
2023
Q2 		$2.59M Sell
43,446
-11,169
-20% -$664K 0.01% 961
2023
Q1 		$3.19M Buy
54,615
+25,041
+85% +$1.51M 0.01% 788
2022
Q4 		$1.83M Buy
29,574
+474
+2% +$28.5K 0.01% 1066
2022
Q3 		$1.65M Buy
29,100
+3,384
+13% +$208K 0.01% 1068
2022
Q2 		$1.64M Buy
25,716
+603
+2% +$38.3K 0.01% 1021
2022
Q1 		$1.63M Buy
25,113
+5,802
+30% +$368K 0.01% 1002
2021
Q4 		$1.28M Buy
19,311
+3,702
+24% +$235K 0.01% 1199
2021
Q3 		$953K Sell
15,609
-2,541
-14% -$162K ﹤0.01% 1310
2021
Q2 		$1.12M Buy
18,150
+375
+2% +$22.8K 0.01% 1216
2021
Q1 		$1.05M Buy
17,775
+90
+0.5% +$5.43K 0.01% 1165
2020
Q4 		$1.06M Sell
17,685
-504
-3% -$28.7K 0.01% 1151
2020
Q3 		$991K Buy
18,189
+6,435
+55% +$347K 0.01% 1097
2020
Q2 		$603K Buy
11,754
+1,653
+16% +$83.1K ﹤0.01% 1273
2020
Q1 		$453K Buy
10,101
+5,580
+123% +$281K ﹤0.01% 1271
2019
Q4 		$241K Buy
+4,521
New +$223K ﹤0.01% 1824
2018
Q4 		– Sell
-4,071
Closed -$228K – 1992
2018
Q3 		$228K Sell
4,071
-600
-13% -$32.8K ﹤0.01% 1860
2018
Q2 		$236K Sell
4,671
-252
-5% -$12.5K ﹤0.01% 1776
2018
Q1 		$242K Sell
4,923
-1,173
-19% -$60.2K ﹤0.01% 1714
2017
Q4 		$314K Sell
6,096
-2,370
-28% -$122K ﹤0.01% 1563
2017
Q3 		$441K Sell
8,466
-600
-7% -$30.8K 0.01% 1322
2017
Q2 		$469K Sell
9,066
-2,685
-23% -$136K 0.01% 1206
2017
Q1 		$591K Buy
11,751
+897
+8% +$44.4K 0.01% 1088
2016
Q4 		$512K Buy
10,854
+3,675
+51% +$174K 0.01% 1080
2016
Q3 		$358K Sell
7,179
-6,327
-47% -$321K 0.01% 1111
2016
Q2 		$650K Buy
13,506
+6,753
+100% +$321K 0.01% 475
2016
Q1 		$308K Hold
6,753
– – 0.01% 952
2015
Q4 		$364K Sell
6,753
-210
-3% -$11K 0.01% 955
2015
Q3 		$344K Sell
6,963
-1,335
-16% -$76.5K 0.01% 1000
2015
Q2 		$484K Buy
8,298
+2,421
+41% +$141K 0.01% 1201
2015
Q1 		$338K Buy
5,877
+1,734
+42% +$94.9K 0.01% 1673
2014
Q4 		$209K Buy
+4,143
New +$202K ﹤0.01% 1982

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Janney Montgomery Scott's IHE Position: Q1 2026 in Review

Janney Montgomery Scott reduced its iShares US Pharmaceuticals ETF (IHE) stake by 34% in Q1 2026, selling an estimated $310K and leaving 6,865 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

Janney Montgomery Scott first reported a position in IHE in Q4 2014 and has held it in 42 quarters since. The position peaked at $3.19M in Q1 2023. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Janney Montgomery Scott held 6,865 shares of iShares US Pharmaceuticals ETF worth $595K as of Q1 2026.
  • Janney Montgomery Scott sold 3,536 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $310K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1937 holding.
  • Janney Montgomery Scott first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and has held it in 42 quarters since.
  • Janney Montgomery Scott's iShares US Pharmaceuticals ETF position peaked at $3.19M in Q1 2023.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.